The Plasma Derivatives Act Article 13
Blood donation institutions may engage in the manufacturing of plasma derivatives with the blood materials collected, or with the approval of the central competent authority, supply such blood materials to other plasma derivative manufacturers.Blood donation institutions may charge cost-based fees for the aforementioned supply to the plasma derivative manufacturers. The amount of said charge shall be submitted to and approved by the central competent authority.
中文原文 血液製劑條例第13條
捐血機構對於所採集之血液原料，得自為血液製劑製造業者或經中央主管機關核准後，提供其他血液製劑製造業者。
捐血機構提供其他血液製劑製造業者，得收取工本費用；其費額，應報中央主管機關核准。
捐血機構提供其他血液製劑製造業者，得收取工本費用；其費額，應報中央主管機關核准。